Login with your work email address to view charts. No credit card required.
| Art Unit: | 1672 — Drug, bio-affecting and body treating compositions |
|---|---|
| Group: | 1670 — Virology, Viral Immunology, And Viral Pathogens, Neurology, Receptors, Cytokines & Recombinant Hormones and Immunoassays and related devices |
| Classes: |
424 — Drug, bio-affecting and body treating compositions 435 — Chemistry: molecular biology and microbiology 530 — Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof 514 — Drug, bio-affecting and body treating compositions 800 — Multicellular living organisms and unmodified parts thereof and related processes 436 — Chemistry: analytical and immunological testing 702 — Data processing: measuring, calibrating, or testing |
| Phone: | (571) 270-3546 |
| Email: | barry.chestnut@uspto.gov |
| Location: | VA 22314 |
| Title: | Pat Examnr Gen Chem |
| Service: | 14 years |
| Grade: | GS-14 |
| 3-Year Grant rate: | 89% over 573 cases |
|---|---|
| Difficulty: | Easier |
| Difficulty Percentile: | 23rd
|
With Examiner Chestnut, you have a 89% chance of getting an issued patent by 3 years after the first office action. Examiner Chestnut is an easier examiner and in the 23rd percentile across all examiners (with 100th percentile most difficult).
Below is the grant rate timeline for Examiner Chestnut, where the timeline is relative to the date of the first office action. The three-year grant rate is the percentage of applications granted at three years after the first office action.
Examiner Chestnut's grant rate is higher than that of Art Unit 1672 and higher than that of the USPTO.
| Average Office Actions Per Grant | |
|---|---|
| Examiner Chestnut | 0.7 |
| Art Unit 1672 | 1.7 |
Subscribe to Premium Examiner Statistics for unlimited access to our examiner statistics.
Subscribe to Premium Examiner Statistics for unlimited access to our examiner statistics.
Subscribe to Premium Examiner Statistics for unlimited access to our examiner statistics.
Subscribe to Premium Examiner Statistics for unlimited access to our examiner statistics.
Disclaimer: We do not provide any guarantees as to the accuracy of the statistics presented above and under
no circumstances will we be liable for any outcome resulting from your reliance on the above statistics.